Talia Flanagan

Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets

Xavier Pépin, Talia Flanagan, David Holt et al. · Molecular Pharmaceutics · 2016 · 119 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Approaches for Establishing Clinically Relevant Dissolution Specifications for Immediate Release Solid Oral Dosage Forms

Andre Hermans, Andreas Abend, Filippos Kesisoglou et al. · The AAPS Journal · 2017 · 63 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

<i>In Vivo</i> Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context

Hans Lennernäs, Anders Lindahl, A. Van Peer et al. · Molecular Pharmaceutics · 2017 · 57 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Formulation factors affecting acceptability of oral medicines in children

Fang Liu, Sejal R. Ranmal, Hannah Batchelor et al. · International Journal of Pharmaceutics · 2015 · 56 citations · Full text

Pharmacy, Oral Medicine, Pharmaceutics +14

Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report

Amitava Mitra, Sandra Suarez‐Sharp, Xavier Pépin et al. · Journal of Pharmaceutical Sciences · 2020 · 54 citations

Pharmacy, Pharmacokinetics, Pharmacology +16